BBC3 Antibody, HRP conjugated is a high-quality polyclonal antibody raised in rabbits against a synthetic peptide derived from human PUMA (Q96PG8) . The HRP conjugation facilitates enzymatic signal amplification in immunoassays, allowing quantitative or qualitative detection of BBC3, a pro-apoptotic protein involved in p53-mediated apoptosis .
The conjugate is optimized for ELISA, where HRP catalyzes colorimetric or chemiluminescent reactions upon substrate addition (e.g., TMB or ABTS) . Key features include:
High sensitivity: HRP amplifies signal output, enabling detection of low-abundance BBC3.
Specificity: Targets the mitochondrial BBC3 protein, critical for apoptosis regulation .
Stability: Glycerol in the formulation prevents aggregation during storage .
While the exact protocol for this specific conjugate is undisclosed, HRP-antibody conjugation typically involves:
Antibody Modification: Introducing thiol groups (-SH) to IgG antibodies using heterobifunctional crosslinkers (e.g., maleimide-activated HRP) .
HRP Activation: Periodate oxidation of HRP’s carbohydrate moieties to generate aldehyde groups for amine coupling .
Purification: Removal of unreacted HRP/antibody via size-exclusion chromatography or scavenger resins to achieve >90% purity .
Antibody Purity: >90% pure IgG by SEC-HPLC or gel electrophoresis .
HRP Quality: >99% purity and >200 units/mg enzymatic activity .
Stoichiometry: Target 2–4 HRP molecules per antibody to avoid polymerization .
Recent advancements in HRP-antibody conjugation highlight methods to improve assay sensitivity:
Lyophilization: Freeze-drying activated HRP increases antibody-HRP binding efficiency, enhancing ELISA sensitivity by ~200-fold compared to classical methods .
Recombinant Conjugates: Genetic fusion of HRP with antibody fragments (e.g., Fab) in Pichia pastoris yields homogeneous conjugates with retained antigen-binding and enzymatic activity .